Return to Library
Hypertrophic cardiomyopathy in children Visual Overview
Topic

Hypertrophic cardiomyopathy in children

💡 What You Need to Know

  • Genetic Basis: Hypertrophic cardiomyopathy (HCM) in children is primarily a genetic disorder, often inherited, causing the heart muscle (myocardium) to thicken abnormally.
  • Heart Muscle Thickening: This thickening, particularly of the left ventricle, can make it harder for the heart to pump blood effectively and relax properly to fill with blood.
  • Impact on Function: The thickened muscle can obstruct blood flow out of the heart (outflow tract obstruction) and impair the heart's ability to fill with blood, leading to symptoms and potential complications.
  • Variable Presentation: HCM can manifest differently in children, from asymptomatic cases detected during screening to severe forms with significant symptoms or sudden cardiac events.

🤒 Associated Symptoms

  • Shortness of Breath (Dyspnea): Especially during physical activity or exertion.
  • Chest Pain: May occur during or after exercise.
  • Fatigue: Unexplained tiredness or reduced exercise tolerance.
  • Palpitations: A sensation of a rapid, fluttering, or pounding heart.
  • Syncope or Dizziness: Fainting or lightheadedness, particularly with exertion or sudden changes in position.
  • Poor Growth/Feeding: In infants, difficulty feeding, poor weight gain, or excessive sweating.
  • Sudden Cardiac Arrest: In rare but serious cases, HCM can be a cause of sudden cardiac arrest, especially during intense physical activity.

🛡 Crucial Precautions

  • Activity Restrictions: Strict avoidance of competitive sports and strenuous physical activity is crucial to reduce the risk of sudden cardiac events. Consult with a pediatric cardiologist for specific guidelines.
  • Regular Cardiology Follow-ups: Adhere to scheduled appointments with a pediatric cardiologist for ongoing monitoring, medication adjustments, and diagnostic testing (e.g., echocardiograms).
  • Medication Adherence: Administer prescribed medications (e.g., beta-blockers, calcium channel blockers) exactly as directed to manage symptoms and improve heart function.
  • Hydration: Maintain adequate hydration, especially during illness or warm weather, as dehydration can worsen outflow tract obstruction.
  • Fever and Illness Management: Promptly address fevers and illnesses, as they can increase cardiac demand. Consult a physician for appropriate management.
  • Genetic Counseling: Consider genetic counseling for the child and family members to understand inheritance patterns and screen at-risk relatives.

🍽 Dietary Directions & Restrictions

  • Adequate Hydration: Ensure consistent and sufficient fluid intake to support cardiac output and prevent dehydration, which can exacerbate symptoms.
  • Balanced Nutrition: Provide a balanced, age-appropriate diet to support growth and development without promoting excessive weight gain, which can add strain to the heart.
  • Avoid Stimulants: Limit or avoid caffeine and other stimulants that can increase heart rate and potentially worsen symptoms.
  • Electrolyte Balance: If diuretics are prescribed, monitor electrolyte levels as advised by the physician and ensure dietary intake supports electrolyte balance.
  • Sodium Intake: Discuss appropriate sodium intake with the cardiologist, especially if there are signs of fluid retention or heart failure.

⚠️ Attendant Guidelines

  • Emergency Action Plan: Develop and share an emergency action plan with all caregivers, including school personnel, outlining steps to take in case of syncope, chest pain, or other cardiac emergencies.
  • CPR Training: Caregivers should be trained in cardiopulmonary resuscitation (CPR) and be aware of the location of automated external defibrillators (AEDs) in common environments.
  • Symptom Recognition: Educate all individuals involved in the child's care about the specific symptoms of HCM and when to seek immediate medical attention.
  • Medication Management: Ensure all caregivers are aware of the child's medications, dosages, and administration schedule.
  • Avoid Over-the-Counter Stimulants: Be cautious with over-the-counter cold medications or decongestants that may contain stimulants and could be detrimental.

🩺 Physician's Perspective

  • Early Diagnosis: Prompt diagnosis through echocardiography is crucial for initiating appropriate management and risk stratification.
  • Personalized Management: Treatment plans are highly individualized, often involving medications like beta-blockers or calcium channel blockers to improve heart function and reduce symptoms.
  • Risk Stratification: Regular assessment of risk factors for sudden cardiac death (SCD) guides decisions regarding activity restrictions and, in some cases, implantable cardioverter-defibrillator (ICD) placement.
  • Multidisciplinary Care: A team approach involving pediatric cardiologists, geneticists, electrophysiologists, and nurses ensures comprehensive care.
  • Family Screening: Recommend cascade screening for first-degree relatives due to the genetic nature of HCM.

🎓 Academic & Nursing Corner

  • Pathophysiology Understanding: Grasp the mechanisms of myocardial hypertrophy, diastolic dysfunction, and potential outflow tract obstruction in HCM.
  • Vital Sign Monitoring: Closely monitor heart rate, rhythm, blood pressure, and respiratory status, noting any changes indicative of cardiac decompensation.
  • Patient and Family Education: Provide thorough education on medication administration, activity restrictions, symptom recognition, and the importance of adherence to the care plan.
  • Psychosocial Support: Address the emotional and social impact of a chronic cardiac condition on the child and family, offering resources and support.
  • Pre- and Post-Procedure Care: Prepare children and families for diagnostic tests (e.g., ECG, echocardiogram, cardiac MRI) and any interventional procedures, ensuring comfort and understanding.

🔬 Clinical Reference Index

  • Sarcomeric Gene Mutations: Common genetic causes include mutations in genes encoding sarcomeric proteins, such as MYH7 (beta-myosin heavy chain) and MYBPC3 (myosin-binding protein C).
  • Left Ventricular Hypertrophy (LVH): Characterized by asymmetric thickening of the interventricular septum or other left ventricular walls.
  • Dynamic Left Ventricular Outflow Tract (LVOT) Obstruction: Occurs in a subset of patients due to systolic anterior motion (SAM) of the mitral valve, leading to increased pressure gradient.
  • Diastolic Dysfunction: Impaired relaxation and filling of the left ventricle, contributing to elevated filling pressures and symptoms.
  • Risk Stratification for SCD: Factors include massive LVH, unexplained syncope, non-sustained ventricular tachycardia (NSVT), abnormal blood pressure response to exercise, and family history of SCD.
  • Treatment Modalities: Pharmacological (beta-blockers, calcium channel blockers, disopyramide), interventional (septal myectomy, alcohol septal ablation), and device-based (ICD implantation).